The IGFBP-3 mRNA and protein levels are IGF-I-dependent and GH-independent in MG-63 human osteosarcoma cells

Molecular and Cellular Endocrinology

Volumn 175, Issue 1-2, 2001, Pages 15-27

  Rosato, Roberto ^a   Gerland, Katia ^b   Jammes, Hélène ^c   Bataille Simoneau, Nelly ^b   Segovia, Berta ^a   Mercier, Louis ^b   Groyer, André ^a,d  

^a HÔPITAL SAINT ANTOINE   (France)

^b LHEA   (France)

^c CEMAGREF   (France)

^d INSERM   (France)

Author keywords

Actinomycin D; Gene expresssion; Growth hormone; Growth hormone receptor; IGFBP 3; Insulin like growth factor I; Osteosarcoma cells

Indexed keywords

DACTINOMYCIN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; MESSENGER RNA; PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OSTEOSARCOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SECRETION; WESTERN BLOTTING;

CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KINETICS; OSTEOSARCOMA; RNA STABILITY; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035946465     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00434-8     Document Type: Article

References (59)

1. Selective effect of thiazides on the human osteoblast-like cell line MG-63
2. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I
3. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones
4. Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts
5. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures
6. Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures
7. Receptors for insulin-like growth factors-I and II in osteoblasts enriched cultures from fetal rat bone
8. High-efficiency transformation of mammalian cells by plasmid DNA
9. Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype?
10. Growth hormone (GH) and prolactin (PRL) regulate IGFBP-3 gene expression in rat b-cells
11. Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells
12. The proline rich region of the growth hormone receptor is essential for Jak2 phosphorylation, activation of cell proliferation and gene transcription
13. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of GH-induced IGF-Binding Protein-3
14. Insulin-like growth factor-I induces cyclin-D1 expression in MG-63 human osteosarcoma cells in vitro
15. Evidence for insulin-like growth factor (IGF)-independent transcriptional regulation of IGF-binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells
16. Osteogenic-protein-1 stimulates production of insulin-like growth factor-binding protein-3 nuclear transcripts in human osteosarcoma cells
17. Insulin-like growth factors and their binding proteins: biological actions
18. Long-term treatment of Laron-type dwarfs with insulin-like growth factor-I increases insulin-like growth factor-binding protein-3 in the absence of growth hormone
19. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4
20. Cellular and molecular effects of growth hormone and estrogen on human bone cells
21. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells
22. Calcitonin directly acts on mouse osteoblastic MC3T3-E1 cells to stimulate mRNA expression of c-fos, insulin-like growth factor-1 and osteoblastic phenotypes (type 1 collagen and osteocalcin)
23. Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in normal state outside of the bloodstream
24. A proteolytic fragment of IGFBP-3 that fails to bind IGFs inhibits IGF and insulin mitogenic effects
25. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells
26. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interaction with growth hormone
27. The type V transforming growth factor b receptor is the putative insulin-like growth factor-binding protein-3 receptor
28. A novel growth hormone response element unrelated to STAT (signal transducer and activator of transcription)-binding site is a bifunctional enhancer
29. Insulin-like growth factor-I (IGF-I) dependent phosphorylation of the IGF-I receptor in MG-63 cells
30. The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells
31. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors
32. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvaria cultures
33. Growth hormone and insulin-like growth factor-I do not activate identical genes in normal human osteoblast
34. Studies on the regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells
35. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
36. New concepts in insulin-like growth factor receptor physiology
37. Growth hormone and bone
38. Normal human osteoblast-like cells consistently express genes for insulin-like growth factor I and II, but transformed human osteoblast cell lines do not
39. Electroporation-mediated gene transfer into hepatocytes: preservation of a growth hormone response
40. Human osteosarcoma cells (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6 phosphate (IGF-II/M6P) receptors and synthetise IGF-II. Autocrine growth stimulation by IGF-II via IGF-I receptor
41. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53 and IGF-independent mechanism
42. IGFs: function and clinical importance. 2 The regulation of osteoblast function by hormones and cytokines with special reference to insulin-like growth factors and their binding proteins
43. Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts
44. Differential activation of STAT3 and STAT5 by distinct regions of the growth hormone receptor
45. Adult human osteoblast-like cells do not express insulin-like growth factor-I
46. Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs
47. Expression of human Growth Hormone (hGH) receptor isoform is predicted dy tissue-specific alternative splicing of exon 3 of the GH receptor gene transcript
48. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
49. (1a,25)-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell line
50. Insulin-like growth factor-I regulate hepatic insulin-like growth factor binding protein-3 by different mechanisms
51. Studies on the regulation of insulin-like growth factor binding protein-3 secretion in human osteosarcoma cells in vitro
52. Skeletal growth factor and other growth factors known to be present in bone marix stimulate proliferation and protein synthesis in human bone cells
53. Role of insulin-like growth factors in steroid modulated proliferation
54. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule
55. Osteogenic protein-1-mediated insulin-like growth factor gene expression in primary cultures of rat osteoblastic cells
56. Recombinant insulin-like growth factor-I induces its own specific carrier protein in hypophysectomized and diabetic rats
57. The generation of insulin-like growth factor-I-sensitive cells by growth hormone action
58. Retinoic acid regulates insulin-like growth factor-binding protein expression in human osteoblast cells